Concepedia

Author

Chris Daige

Exelixis (United States)

Also Known As

C. L. Daige, Chris Daige, Chris L. Daige

11

Publications

1.2K

Citations

6

H-Index

27

Concepts

All Affiliations

Exelixis (United States)University of California San DiegoHoward Hughes Medical InstituteUniversity of Virginia Health SystemXalud Therapeutics (United States)
CD

About

Chris Daige is an author at Exelixis (United States) specializing in medicine, vascular biology, and metabolic syndrome.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

488

2

Health Sciences

1

1

233

3

Natural Sciences

1

1

161

4

Biochemistry

1

1

161

5

Cell Biology

1

1

233

Chris Daige

×

6

Publications

1.2K

Citations

6

H-Index

YearCitations

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

Rajendra K. Tangirala, Eric D. Bischoff, Sean B. Joseph,

Proceedings of the National Academy of Sciences

2002

436

Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists

Eric D. Bischoff, Chris Daige, Diane Thomas,

Arteriosclerosis Thrombosis and Vascular Biology

2004

281

Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression

Brandee Wagner, Annabel F. Valledor, Gang Shao,

Molecular and Cellular Biology

2003

233

Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)

Brenton Flatt, Richard Martin, Tielin Wang,

Journal of Medicinal Chemistry

2009

161

Non-redundant roles for LXR  and LXR  in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice

Eric D. Bischoff, Chris Daige, Mary Petrowski,

Journal of Lipid Research

2010

94

Non-redundant roles for LXRα and LXRβ in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice

Eric D. Bischoff, Chris Daige, Mary Petrowski,

Journal of Lipid Research

2009

26

Page 1